zacks.com / .zacks-com / Page 4

FedEx's shares are up 16.2% in three months, powered by cost cuts and upbeat FY26 guidance --- but fuel spikes and trade-policy shifts cloud the near term.

ImmunityBio responds to an FDA warning over misleading Anktiva claims and outlines compliance fixes as strong sales growth and expansion efforts remain in focus.

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Banco Comercial Portugues (BPCGY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

B considers slowing Reko Diq development as rising security risks trigger a full project review, with higher capital costs and delays now expected.

BASFY acquires AgBiTech to boost biological insect control, expanding sustainable crop solutions and strengthening its Agricultural Solutions business.

Mutual Fund Report for BULIX ...

Explore Hartford mutual funds such as HNCCX, HIADX and SIDNX for broad market opportunities.

Sector ETF report for ZAP ...

Sector ETF report for CLOU ...